Phase 1/2 × Central Nervous System Neoplasms × Radiotherapy × Clear all Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
Phase 1/2 Terminated
7 enrolled 9 charts
RTOG 0913
Phase 1/2 Completed
279 enrolled 14 charts
Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
Phase 1/2 Unknown
50 enrolled
DEND/TIA
Phase 1/2 Completed
6 enrolled
Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1/2 Completed
217 enrolled 12 charts
Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase 1/2 Completed
60 enrolled 10 charts
Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors
Phase 1/2 Completed
30 enrolled
Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme
Phase 1/2 Completed
58 enrolled
Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme
Phase 1/2 Completed
40 enrolled
Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
Phase 1/2 Terminated
7 enrolled
Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1/2 Unknown
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors
Phase 1/2 Completed
10 enrolled
Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1/2 Completed
20 enrolled
Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
Phase 1/2 Completed